Page last updated: 2024-12-09
diphenylbutadiene
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
diphenylbutadiene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 609776 |
MeSH ID | M0451784 |
Synonyms (11)
Synonym |
---|
4165-81-5 |
(1-phenyl-1,3-butadienyl)benzene |
1-phenylbuta-1,3-dienylbenzene |
AKOS015967523 |
diphenylbutadiene |
1,1-diphenyl-buta-1,3-diene |
GUPMCMZMDAGSPF-UHFFFAOYSA-N |
benzene, 1,1'-(1,3-butadienylidene)bis- |
(1-phenyl-1,3-butadienyl)benzene # |
1,1-diphenyl-1,3-butadiene |
buta-1,3-diene-1,1-diyldibenzene |
Research Excerpts
Overview
Diphenylbutadiene (DPBD) is an optical brightener incorporated into a wide range of polymeric materials.
Excerpt | Reference | Relevance |
---|---|---|
"Diphenylbutadiene (DPBD) is an optical brightener incorporated into a wide range of polymeric materials. " | ( Determination of diphenylbutadiene by liquid chromatography-UV-fluorescence in foodstuffs. Paseiro Losada, P; Sanches Silva, AT; Sendón García, R, 2004) | 2.11 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (10)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (10.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 2 (20.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 32.21
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (32.21) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 11 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |